Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.60B
Revenue (ttm)	3.46B
Net Income (ttm)	172.01M
Shares Out	n/a
EPS (ttm)	30.14
PE Ratio	26.73
Forward PE	n/a
Dividend	5.00 (0.62%)
Ex-Dividend Date	Jul 25, 2025

Volume	10,945
Average Volume	7,373
Open	801.05
Previous Close	806.20
Day's Range	801.05 - 839.00
52-Week Range	762.60 - 1,753.95
Beta	0.04
RSI	44.84
Earnings Date	Aug 8, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,497
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.